Moderna Inc and Pfizer Inc launched two 30,000-subject trials of COVID-19 vaccines that could clear the way for regulatory approval and widespread use by the end of this year, the companies said on...
from NDTV News - Special https://ift.tt/3f0cYIt
No comments:
Post a Comment